The Australian Self Medication Industry (ASMI) has revealed its 2015 Committee of Management which will drive “an ambitious advocacy program in 2015”.
The Australian Self Medication Industry (ASMI) has released the line-up for its 2015 Committee of Management, with ASMI Executive Director, Dr Deon Schoombie said the “talented and strong Committee of Management” would be “driving an ambitious advocacy program in 2015”.
“I’m greatly looking forward to working with them in the year ahead,” Dr schoombie said
The 2015 Committee of Management includes:
Mark Sargent, ASMI President; General Manager Consumer Care Australia & New Zealand, Bayer Australia Limited
Violeta Delgado, ASMI Vice President (Treasurer); Head of ANZ at Novartis Consumer Health
Paul Rose, ASMI Vice President (Secretary); General Manager ANZ at Pfizer Consumer Healthcare
Robert Barnes, Head of Consumer OTC Division, Aspen Pharmacare Australia
Brett Charlton, Director Consumer Healthcare, Sanofi Consumer Health
Vincent Cotard, Vice President/General Manager, GlaxoSmithKline Consumer Healthcare
Gaurav Jain, Regional Director ANZ, Reckitt Benckiser
James Jones, Commercial Country Manager, Takeda Pharmaceuticals Australia
Phil Lynch, Managing Director, Australia/New Zealand, Johnson & Johnson Pacific
Alan Oppenheim, Managing Director, Ego Pharmaceuticals.